CADIAN CAPITAL MANAGEMENT, LP

Position in MXCT — Maxcyte, Inc.

CIK 1423686 NEW YORK, NY

Position in MXCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,707,434

+$1,496,206 QoQ

Shares Held

2,201,166

+27.8% QoQ

Ownership

2.13%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

of 123 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CADIAN CAPITAL MANAGEMENT, LP holds $151,468,147 across 4 Medical Devices names. MXCT ranks #4 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SIBN	SI-BONE, Inc.	3,347,574	$54,632,407
2	BSX	Boston Scientific Corp	1,105,132	$47,167,033
3	TCMD	Tactile Systems Technology Inc	1,576,940	$46,961,273
4	MXCT	Maxcyte, Inc. This page	2,201,166	$2,707,434

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,707,434	2,201,166	+27.8%	Shares	Sole	2026-08-14
2026-03-31	$1,211,228	1,722,942	-53.2%	Shares	Sole	2026-05-15
2025-12-31	$5,708,730	3,683,052	-55.2%	Shares	Sole	2026-02-17
2025-09-30	$12,999,612	8,227,603	-7.7%	Shares	Sole	2025-11-14
2025-06-30	$19,433,557	8,914,476	-11.1%	Shares	Sole	2025-08-14
2025-03-31	$27,375,694	10,027,727	+7.3%	Shares	Sole	2025-05-15
2024-12-31	$38,872,803	9,344,424	+14.1%	Shares	Sole	2025-02-14
2024-09-30	$31,855,007	8,188,948	+7.4%	Shares	Sole	2024-11-14
2024-06-30	$29,881,928	7,622,941	+16.2%	Shares	Sole	2024-08-14
2024-03-31	$27,488,427	6,560,484	+16.2%	Shares	Sole	2024-05-15
2023-12-31	$26,531,020	5,644,898	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.